During the forecast period, the global rabeprazole sodium market is expected to rise at a considerable CAGR. The market growth is being driven by the rising prevalence rate of gastroesophageal reflux diseases (GERD), duodenal ulcers, and other gut-related infections and diseases globally, which has surged the demand for better treatment options. As per the World Gastroenterology Organization, the prevalence rate of GERD is growing rapidly across the world. It was valued at approximately 2.5%-6.6% in South East Asia and almost 13.8%-25.8% in North America. Moreover, in 2019, the global prevalence of duodenal or peptic ulcer prevalence was approximately 8.09 million representing a 25.82% increase from 1990. The increase in the number of cigarette smokers, alcohol/tobacco consumers, and a significant increase in food habits are the major cause of these diseases. The prevalence of acid reflux and related symptoms has increased across the globe by nearly 50% over the last decade. This disorder not only has major effects on the health and quality of patient lives but also extends to the healthcare system and economy.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/rabeprazole-sodium-market
The prominent players in the market are focusing on acquisition and partnership collaboration with other market players to broaden their product offering in order to fulfill the growing market demand. For instance, in December 2021, Pfizer Inc. acquired Arena Pharmaceuticals, Inc along with its all the outstanding shares for $100 per share in an all-cash transaction for a total equity value of approximately $6.7 billion, via a definitive agreement. Through this acquisition, the company acquired Arena’s portfolio which includes diverse and promising development-stage therapeutic candidates in gastroenterology, including etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator currently in development for a range of immuno-inflammatory diseases including gastrointestinal and dermatological diseases.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- including ASN Co., Intas Pharmaceutical Ltd., Pfizer Inc., Sandoz Inc. (Novartis International AG)), Teva Pharmaceutical Industries Ltd., and others.?
Key questions addressed by the report
- What is the market growth rate?
- That segment and region dominate the market in the base year?
- That segment and region will project the fastest growth in the market?
- How does COVID-19 impact the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Rabeprazole Sodium Market Report Segment
By Type
- Rabeprazole Sodium Monohydrate
- Rabeprazole Sodium Crystalline
By Application
- Gastroesophageal Reflux Disease Treatment
- Duodenal Ulcer Treatment
- Others
A full report of Rabeprazole Sodium Market is available at: https://www.omrglobal.com/industry-reports/rabeprazole-sodium-market
Rabeprazole Sodium Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- including ASN Co.
- Intas Pharmaceutical Ltd.
- Pfizer Inc.
- Sandoz Inc. (Novartis International AG))
- Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
